Fourth time's the charm? blue­bird picks up new fi­nance chief; New CEOs here and there

blue­bird bio has been able to cinch two FDA OKs, one for Zyn­te­glo and the oth­er for Skysona, in quick suc­ces­sion, but has had …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.